{"name":"Fenway Community Health","slug":"fenway-community-health","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"TRUVADA + Raltegravir","genericName":"TRUVADA + Raltegravir","slug":"truvada-raltegravir","indication":"HIV-1 infection treatment","status":"marketed"}]}],"pipeline":[{"name":"TRUVADA + Raltegravir","genericName":"TRUVADA + Raltegravir","slug":"truvada-raltegravir","phase":"marketed","mechanism":"This combination blocks HIV replication by inhibiting reverse transcriptase (TRUVADA) and integrase (raltegravir), preventing the virus from copying itself and integrating into host DNA.","indications":["HIV-1 infection treatment","HIV-1 pre-exposure prophylaxis (PrEP) when combined with raltegravir"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOSElheGMyYlYzNjVQaW9QWVctVHlDeWJWaXdFSVRRcW5wNFJQU3YtYUI2QU1SYUFfcUNDZVlaMmt5c3lCSEtpT2p0dVAxTkh0Y2VsU2xDalRaLWdScFJIX3hWOXloeFNnSy1FdmY1WUY5WXUzeWNtRG9QTkV5VVNpbktUN3ExNE1fQjVHeVdwcmpsUjBiOGdwQ0RWMlZMZw?oc=5","date":"2025-12-24","type":"pipeline","source":"Fenway Health","summary":"Resilience in Action: A Year at The Fenway Institute 2025 - Fenway Health","headline":"Resilience in Action: A Year at The Fenway Institute 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxQSWFfbm9MWG54aUUyTDNhRkFRMHhjcmtKR3p1UHhfaHF5NXNGbE1UWFZYRVlTc3hvQmxUZmJDZlVJM2hnSGNSTjZvVjl6NXhtV2ZXUXZZZGQ0LW1ydDJrNUVqZkZQcVVYTTJST3Bqd1Y4cHhJVElhQ0NYbnd0MWxKRmFoWnJ4WnZrbUZ1OXFCdXB4ZTRzMkhuTmYzTHN6MHJsUUlFWGtCUFREQ2htQkpIczVCT3ltTlNEQmVnLXRFRXE?oc=5","date":"2025-10-22","type":"pipeline","source":"The Provincetown Independent","summary":"OCHS to Halt Gender-Affirming Care for Trans Youth - The Provincetown Independent","headline":"OCHS to Halt Gender-Affirming Care for Trans Youth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNQ3lBTjQzU3VHOGJuTDRsRlFJaW1BTUVYNUs3V25aM3VZQ3FIaXFWS0Zrb196TnRVR2JtSmpwY2VhdW53MmtFZmRBYXNkRm05aU1ZSEdhRXJmc2kyM2N4S0paN1dtSFNkLWdocVR5bzRYMU1QOTg0OHVBN3l4aXdrVTRka1luQmZQYmlzOUg0dnlOeFlvMksxQ3RtMA?oc=5","date":"2025-10-16","type":"pipeline","source":"statnews.com","summary":"Large LGBTQ+ health center will stop gender-affirming care for those under 19 - statnews.com","headline":"Large LGBTQ+ health center will stop gender-affirming care for those under 19","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxOUWg2WTUzTjU4T1FtSDdEOFJCVzVxU2hka3JEckJHNDBkZFNYa2o4ZUJuS1R6ZXpUR2dZZzNjMHdGS25vWGtYX25Da2pJT0ZEY3I4N1B6YUNUaFlGSXNlMWRpTzA0Q0JDSWFzbTYxdWF6MEY0a3p2NVlYSWc0Ym52Wlg1bEVGdkszV1d2d3UwRHJ2RmtZcTFyRE9jaUJSMXloMTRHRC1XQW8ybGRYa1ktcg?oc=5","date":"2025-08-27","type":"pipeline","source":"businesswire.com","summary":"eternalHealth Announces 2025 Healthcare Hall-of-Famers - businesswire.com","headline":"eternalHealth Announces 2025 Healthcare Hall-of-Famers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxPNTJoSkV2azZ4V2FrVkV4c3oyQVpjYUUzQUlXZWNkcURMdWs0YWM0NzZMamE5aHVNaENtUVlPS09pbDN1d1NESHhwMnFzbmZEcUtfM1hmTnlQdnpNWHJoNDZONE1aWVgzTmxuTnhTMWx3SHdkWXZWeVF0Sml4SF9hZ3ZlRW4zamxXZzFBTzF1dWk3a3dYODJVeDlhMWYyVlBOYkZWRVBrWkNJbWtJWG5UbFVBNFdDREhfTFlNQmNKbVJMRGdYelhiYUlwV0VMZw?oc=5","date":"2025-05-20","type":"pipeline","source":"Fenway Health","summary":"Fenway Health’s Strides for Action Walk & Run Kicks off 2025 Massachusetts LGBTQIA+ Pride Month on Sunday, June 1 - Fenway Health","headline":"Fenway Health’s Strides for Action Walk & Run Kicks off 2025 Massachusetts LGBTQIA+ Pride Month on Sunday, June 1","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPY2RrTU1ydkRobm5PSVN0OHRxb0NFbmlKbzhBZ2R4T0xCYjBvQUtMbG43My12VzlLS09qVElYSUFZX19VY1FFRlNJTFJWeG1RalY5Qy1MTnZOQ0ZpQ3JsODg0TVdYMFNaa1pCRzVSOFllSDhRYXVkU0stbFcxTkRINTBULTBQNkxPc2NfZXR5YkcxdnRHSTZrN3MyZ3hXc3Bl?oc=5","date":"2024-06-06","type":"pipeline","source":"Pharmaceutical Executive","summary":"Blue Cross Blue Shield of Massachusetts Expands Support for LGBTQIA+ Members - Pharmaceutical Executive","headline":"Blue Cross Blue Shield of Massachusetts Expands Support for LGBTQIA+ Members","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxNRU80M1dFOGRFdXNJR1RhMmNuSWJjaEVVWG8tUk9SaEhxNWFUYTlNUy12WXRWMkpTMThNSUJfenBtbVloeWFaVzI4c2RXRjVFYWJJbFFFUDhWR0tUZkhTUWcxZzNJNkhhVEVCM085UXdPTDJacWlUeVVYMm5VZG5kNFpFQl8?oc=5","date":"2022-07-01","type":"pipeline","source":"Fenway Health","summary":"Fenway Health Welcomes New Family Medicine Providers - Fenway Health","headline":"Fenway Health Welcomes New Family Medicine Providers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxOWC1jbHRQdVIwcHFPMjFhQU8wNXVMNlZ4d2xJZjJUTlJZaE52VUM4Q2x3OHNFMXJSamVVTi1BY2xjV1plbzNaN29tbHI1eGg0ZzVDUGZsRzdBdmVKRFpmeWVMZElqbUxwTnU5MTFBclY0d1pURGY5cmpzN3FWd3JCdWplVmhOYWJZbFdLYXBpMUU1c1F4RnpRc0NBOXBWODFRMEdWTkN4NlZ3XzdGTEtyWGRxdnJCZWxkNV81cUZUdmN0eHpjYXhYTjJ0VGM?oc=5","date":"2022-03-17","type":"trial","source":"Fierce Pharma","summary":"Fenway Health Builds Community Trust to Bring Clinical Trials to Underserved Populations - Fierce Pharma","headline":"Fenway Health Builds Community Trust to Bring Clinical Trials to Underserved Populations","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxQMGVsLVdBQi1UVnFHd0EtYkRyZDRURm52OWRnWnVEbVZGZUVlZElVcGJWOTdZRUZ4eTFKb2xVZHF0MUo3amtZel9oMzNTWERsLXQ5N05jTVY3VWkteERfRmJSRURId205dWFVQ045VWNrVDBsZVJ6U2FyQXBqUFZxc3NBM00?oc=5","date":"2021-10-07","type":"pipeline","source":"TheBody","summary":"Are Health Centers Needlessly Prescribing Pricey Descovy for PrEP Because They Get a Government Kickback? - TheBody","headline":"Are Health Centers Needlessly Prescribing Pricey Descovy for PrEP Because They Get a Government Kickback?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE9CbFVPR0pIalVUbC1yNzJKaXZyT2JRTWpWS3NhMTVodWFOLTYweTZzU05wV1NjMDFMZXUyaHR1d0xQTi1YdmNzZVZERlF3U1pxbzZDYlRtelh4NzBpWUlEMUczTXhLN0tNSXNJ?oc=5","date":"2021-01-11","type":"pipeline","source":"UNM Newsroom","summary":"Wilterding named director of SHAC - UNM Newsroom","headline":"Wilterding named director of SHAC","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQakNTczB1aHVSNWZzLThVR0hxOVFEdjFyTV9tRmZKOGVkbWRoYU5OaDFmLWs4OFU1WlZKdHJ1TXd5RHFQQV9nbXZycFZUV3QtSFNRSjlMNEZaMnZfOWxaT0FfYnVUZlYzUVhQNjZHd3Q3TEpyZUtIc1k4M19EYTBfdTZPcE1LZ0NjbVdudEFR?oc=5","date":"2020-07-08","type":"pipeline","source":"Fenway Health","summary":"Announcing Our New Fenway Health Board of Directors Members - Fenway Health","headline":"Announcing Our New Fenway Health Board of Directors Members","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNRnRfS2lXZnRFQWxDV192V3l1cDZHM3dCZ21hWTBNeW5hOUdxY1dtRmJWYjVGQzVNSGxpWk5EYnlBNThfQVVDeTY2Mlc5S0c1X0RBYktJbkxieDBpbTlKSlNRWldEc0FjSVlHd19zZjhRMXZXUzM0ZWRINVAyZmI3NVFPQWZfZzRSVmdUX19YbDM1UGVfVE1BNlFvMVM?oc=5","date":"2020-06-19","type":"trial","source":"Fenway Health","summary":"Entering Phase Two and Restoring Some Onsite Services at Fenway Health - Fenway Health","headline":"Entering Phase Two and Restoring Some Onsite Services at Fenway Health","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}